Sunday, November 17, 2024

Latest:

Why comprehensive metrics matter in patient outcome studies
Raising awareness about pancreatic cancer: A message from Dr. William E. Fisher
Brain stars hold our memories
Adult allergies: Q&A with Dr. David Corry
Quitting smoking: tips for lung cancer awareness month

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

steroid receptor coactivator

USP15 could be a target in ovarian cancer scientists have been looking for

May 8, 2018 lysosome, ovarian cancer, ovarian steroids, p53, p53-R175H, proteasome, Research, steroid receptor coactivator, USP 15

Ovarian cancer is currently treated with surgery and chemotherapy. Chemotherapy for ovarian cancer is based on drugs that act on any cell that is rapidly

From The Labs

New class of small molecule, SI-2, can drug the ‘undruggable’ steroid receptor coactivator-3

June 16, 2016 Cancer, drugs, SI-2, SRC-3, steroid receptor, steroid receptor coactivator

By Ana María Rodríguez, Ph.D. Steroid receptor coactivator-3, which is well-known for its role in cancer formation and proliferation, is usually considered ‘undruggable’ because this nuclear

From the Labs: Aging signs.